
U.S. FDA issues five observations to Aurobindo Pharma arm’s API plant
The Hindu
Aurobindo Pharma's Apitoria Pharma facility near Hyderabad receives 5 observations from U.S. FDA during inspection.
More Related News

Scaling Artificial Intelligence(AI) at the speed at which consultants project is not possible by the laws of physics and may not be environmentally sustainable, said Tanvir Khan, who is the Executive Vice President and Chief Operating Officer of NTT DATA North America, part of the Japanese technology services and data centre company NTT Data, in an interview with The Hindu.












